A clear path to the clinic with scalable manufacturing of mRNA, oligos, and custom reagents
TriLink BioTechnologies is expanding to a new global headquarters and state-of-the-art manufacturing campus. Our expertise is now combined with enhanced GMP capabilities to take your innovation from research to the clinic.
TriLink BioTechnologies is actively responding to the COVID-19 pandemic.Learn More >
About TriLink BioTechnologies
TriLink BioTechnologies, part of Maravai LifeSciences, is your CDMO for overcoming challenges in the synthesis and scale-up of nucleic acids, NTPs and mRNA capping analogs with scale-up expertise and unique mRNA production capabilities, including its patented CleanCap® mRNA capping technology. TriLink continues to expand its cGMP and general manufacturing capacity at its new global headquarters to support mRNA, oligonucleotide & plasmid therapeutic, vaccine and diagnostic customers.
CDMO Service Solutions
Hot Start PCR & RT-PCR Reagents
Next Generation Sequencing Reagents
CleanCap® - optimized co-transcriptional capping for vaccine and therapeutic applications.